MDK and glioblastoma: The survival of GBM tumor spheres was significantly decreased in a dose-dependent manner after treatment with two independent Chk inhibitors, AZD7762 and CHIR-124 (Fig. 5d, Supplementary Fig. 14a) compared to treatment with MDK neutralization alone35,36.